CAS: 339086-79-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Rovelizumab REF: TM-T77166CAS: 339086-79-2 | - - - | To inquire | Tue 03 Dec 24 |
 | Rovelizumab REF: 3D-CLA1226CAS: 339086-79-2 | - - - | To inquire | Wed 11 Dec 24 |
Rovelizumab
CAS:339086-79-2
Rovelizumab: humanized anti-CD11/CD18 antibody for MS, hemorrhagic shock, MI, and stroke research.
Color and Shape:
Liquid
Ref: TM-T77166
| 5mg | To inquire |
Estimated delivery in United States, on Tuesday 3 Dec 2024
Rovelizumab
CAS:339086-79-2
Humanized whole monoclonal antibody targeting CD11 and CD18; designed to treat haemorrhagic shock
Ref: 3D-CLA1226
| Undefined size | To inquire |
Estimated delivery in United States, on Wednesday 11 Dec 2024
